Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Gagua Clinic | Healthcare Services | 22.4% | 81st pct | 268 |
| Multiprofile Hospital -… | Healthcare Services | 9.8% | 50th pct | 268 |
| Western Regional Center… | Healthcare Services | 8.8% | 47th pct | 268 |
| Chachava Clinic | Healthcare Services | — | no FY data | 268 |
| Israeli-Georgian Medica… | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 3 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Ratio — FY 2024 | Multiprofile Hospital -… | Western Regional Center… | Gagua Clinic | Chachava Clinic | Israeli-Georgian Medica… |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 78.1% | 78.0% | 87.0% | — | — |
| EBITDA Margin | 9.8% | 8.8% | 22.4% | — | — |
| EBITDAR | 2,967 | 2,962 | 6,534 | — | — |
| EBITDAR Margin | 10.0% | 10.0% | 22.4% | — | — |
| EBIT Margin | 0.8% | 0.1% | 19.9% | — | — |
| Net Profit Margin | -6.4% | -5.0% | 18.8% | — | — |
| Operating Expense % of Sales | 68.6% | 69.5% | 67.7% | — | — |
| Returns | |||||
| Return on Assets (ROA) | -11.5% | -10.2% | 24.9% | — | — |
| Return on Equity (ROE) | N/A | N/A | 29.9% | — | — |
| ROIC [EBIT / Invested Capital] | 3.0% | 0.9% | 30.8% | — | — |
| Leverage & debt balances | |||||
| Debt-to-Assets | 99.8% | 93.3% | 7.5% | — | — |
| Debt-to-Equity | -2.20x | -1.65x | 0.09x | — | — |
| Debt-to-EBITDA | 5.63x | 5.18x | 0.25x | — | — |
| Equity-to-Assets | -45.4% | -56.6% | 83.4% | — | — |
| Net Debt | 15,706 | 12,837 | 520 | — | — |
| Cash & Equivalents | 683 | 602 | 1,136 | — | — |
| Total Debt | 16,389 | 13,439 | 1,656 | — | — |
| Liquidity & working capital | |||||
| Current Ratio | 0.66x | 0.56x | 1.06x | — | — |
| Quick Ratio | 0.55x | 0.47x | 1.02x | — | — |
| Cash Ratio | 0.07x | 0.05x | 0.35x | — | — |
| Total Current Assets | 6,715 | 6,606 | 3,477 | — | — |
| Total Current Liabilities | 10,176 | 11,693 | 3,289 | — | — |
| Inventory | 1,125 | 1,117 | 136 | — | — |
| Trade Receivables | 4,896 | 4,785 | 2,205 | — | — |
| Trade Payables | 3,943 | 3,771 | 2,005 | — | — |
| Net Working Capital | -3,461 | -5,087 | 188 | — | — |
| Net Working Capital % of Revenue | -11.6% | -17.2% | 0.6% | — | — |
| Trade Working Capital | 2,078 | 2,131 | 336 | — | — |
| Trade Working Capital % of Revenue | 7.0% | 7.2% | 1.2% | — | — |
| Change in Trade Working Capital | N/A | N/A | N/A | — | — |
| Turnover & efficiency | |||||
| Inventory Turnover | 5.79x | 5.83x | 27.88x | — | — |
| Days Inventory Outstanding (DIO) | 63.1 | 62.6 | 13.1 | — | — |
| Receivables Turnover | 6.07x | 6.18x | 13.24x | — | — |
| Days Sales Outstanding (DSO) | 60.1 | 59.0 | 27.6 | — | — |
| Payables Turnover | 1.65x | 1.73x | 1.89x | — | — |
| Days Payable Outstanding (DPO) | 221.1 | 211.5 | 193.0 | — | — |
| Cash Conversion Cycle | -97.9 days | -89.8 days | -152.4 days | — | — |
| Asset Turnover | 1.81x | 2.06x | 1.33x | — | — |
| Cash flow & dividends | |||||
| Operating Cash Flow | 1,752 | 1,756 | 6,334 | — | — |
| Free Cash Flow (OCF − Capex proxy) | 1,520 | 1,526 | 4,680 | — | — |
| Cash Conversion (OCF / EBITDA) | 60.1% | 67.6% | 96.9% | — | — |
| Dividends Declared | 901 | 901 | 3,810 | — | — |
| Dividend Payout Ratio | N/A | N/A | 69.4% | — | — |